Fundraising Fox

BGV

Venture capitalActively deploying

Silicon Valley · Seed–Late Stage · 10 people tracked

Also known as BGV Investments

Fox Verdict
Sign up to see your fit

Investment thesis

BGV is a cross-border VC platform rooted in Silicon Valley that backs enterprise-focused B2B technology companies, deploying capital from seed stage to IPO. The firm concentrates on what it calls Enterprise 5.0 companies and cross-border innovation, targeting startups driving leapfrog shifts in enterprise automation and productivity by combining intelligent machines with human ingenuity while emphasizing responsible, human-centric design. Founded by immigrant entrepreneurs-turned-investors, BGV positions itself to provide not only financing but also operational expertise, global resources, and cross-border advisory support to help founders build global B2B technology companies.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
HQ
Silicon Valley, California, US
Instruments
Equity
Founded
2003
Last 12 months
2 investments
Tracked investments
20

Team · 10 people

from public directories

What they invest in

from 14 of 20 portfolio companies

AI & Machine Learning ×9SaaS ×7Biotech ×5Enterprise Software ×5Healthtech ×5Developer Tools ×3Deep Tech ×2Medical Devices ×2

HQs:United States×12Germany×1United Kingdom×1

Investments · 20 tracked

founders shown can be your intro path

By year:2026 · 12025 · 42023 · 22020 · 12019 · 12016 · 110 dated

Brenigbrenigther.comin𝕏✓ verified

Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery.

AI & Machine LearningBiotechHealthtech

Megan McGill(Chief Executive Officer)Iain Dukes(Chief Business Officer / Chairman of the Board)Nikolay Savchuk(Chief Operating Officer)Tien Dam(Chief Medical Officer)

Co-investorsNew Enterprise Associates (NEA)OrbiMedTorrey Pines Investment

Dunaddunadtx.comin✓ verified

Dunad Therapeutics is a biotech company developing oral small-molecule medicines using a covalent chemistry discovery platform to target neurodegenerative diseases such as ALS, Parkinson's disease, and FTD.

BiotechDeep TechCambridge, GB

Pearl Huang(President & CEO)Stephen Huhn(CMO)

Co-investorsAlpha Wave GlobalEpidarex Capital

Lyzrlyzr.aiin𝕏✓ verified

Lyzr builds infrastructure and platforms for deploying production-grade AI agents in enterprises, with emphasis on governance, security, observability, and human oversight.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSJersey City, US

Siva Surendira(Founder & CEO)inSurendirasiva Selvaraj(Executive Officer, Director)Jithin George(Founder)in

BoardMadhu Shalini Iyer(Director)inHenry Ford III(Director)

Co-investorsRocketship.vcAccenture VenturesArka Venture LabsBetter CapitalGFT VenturesIn-Q-Tel+1 more

6d bytes inc.Jan 2025SEC filingmedium confidence

Sunnyvale, US

Vipin Jain(Executive Officer, Director)Venkateswaran Ayalar(Executive Officer, Director)

BoardVikram Mehta(Director)Veronica Wu(Director)

Board seatEric Benhamou· per SEC Form D · $3.1M raise · filed Jan 2025

Datawizzdatawizz.aiin𝕏Aug 2025

Berkeley, US

Iddo Gino(Executive Officer, Director, Promoter)Sigal Shaked(Executive Officer, Director)

Board seatEric Buatois· per SEC Form D

Co-investorsBenhamou Global VenturesHuman Capital

MadKudumadkudu.cominDec 2019acquired by HG InsightsSEC filingmedium confidence

AI & Machine LearningEnterprise SoftwareMarketing TechSaaSSales TechMountain View, US

Paul Cothenet(Founder)Anselme Le Van(Founder)

Board seatEric Buatois· per SEC Form D · $6M raise · filed Jan 2020

Co-investorsMatchstick VenturesTechstarsBenhamou Global Ventures

NxGn DataApr 2016SEC filingmedium confidence

Irvine, US

Nader Salessi(Executive Officer, Director)Vladimir Alves(Director)

BoardAmir Nayyerhabibi(Director)

Board seatEric Buatois· per SEC Form D · $13.5M raise · filed May 2016

NypitFeb 2025SEC filingmedium confidence

Fremont, US

Chris Jodoin(Executive Officer)Jagadeesh Ambati(Executive Officer, Director)

BoardKazuhide Kikuchi(Director)

Board seatRon Sege· per SEC Form D · $15M raise · filed Mar 2025

Onymosonymos.comin𝕏Jan 2020SEC filingmedium confidence

Onymos offers DocKnow, a document and data processing platform for clinical laboratories that captures, validates, and enriches intake documents such as test requisition forms and medical records.

AI & Machine LearningCloud ComputingDeveloper ToolsHealthtechSaaSRedwood Shores, US

SHIVAGURU NATHAN(Executive Officer, Director)Shiva Nathan(Founder)inShiva N(Founder)Bhavani Vangala(CTO)in

Board seatEric Buatois· per SEC Form D · $2.2M raise · filed Feb 2020

Co-investorsGreatPoint VenturesBenhamou Global VenturesEngineering CapitalIndustry Ventures

Anetaaneta.companyMay 2023

Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsPebblebedAndera PartnersForbionFountain Healthcare PartnersHTGFPMV+2 more

Artica Therapeuticsartica-tx.cominNov 2023

Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.

BiotechDeep TechHealthtech

Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in

Co-investorsBioGeneration VenturesThuja CapitalSeroba Life Sciences

Bayshore Networksbayshorenetworks.com

Bethesda, US

Francis Cianfrocca(Director)Bob Lam(Executive Officer)Michael Dager(Executive Officer, Director)

BoardAlberto Yepez(Director)Christopher T Winkler(Director)Anik Bose(Director)in

Co-investorsEvolution Equity PartnersBenhamou Global Ventures

Complement Therapeuticscomplementtx.com

Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.

BiotechDigital HealthHealthtechMedical DevicesMunich, DE

Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in

Co-investorsHadean VenturesSeroba Life SciencesBioGeneration VenturesCambridge Innovation CapitalForbionGimv

Everest Labseverestlabs.aiin𝕏

EverestLabs builds RecycleOS, an AI-powered operating system for recycling plants that uses computer vision, AI, and robotics to identify and sort recyclable materials in Material Recovery Facilities (MRFs).

AI & Machine LearningCircular EconomyClimate TechImpact & Social GoodRobotics

Co-investorsSierra VenturesTransLink CapitalUnanimous CapitalXplorer CapitalBenhamou Global VenturesHike Ventures

Evincedevinced.com

Evinced offers an AI-powered chatbot focused on digital accessibility that answers developer and team questions, reviews code for accessibility issues across web and mobile frameworks, and can read design screenshots.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSPalo Alto, US

Navin R. Thadani(Founder)inGal Moav(Founder)

Co-investorsBenhamou Global VenturesCapital One VenturesEngineering CapitalInsight PartnersM12 (Microsoft's Venture Fund)

Fiddler AIfiddler.aiin𝕏Jan 2026 · $30M

Fiddler AI provides an AI observability and control platform offering experiments, monitoring, guardrails, and governance for enterprise AI agents and compound AI systems.

AI & Machine LearningData & InfrastructureEnterprise SoftwarePalo Alto, US

Krishna Gade(Founder & CEO)in

Co-investorsAngel Collective Opportunity FundaVentureBenhamou Global VenturesCisco InvestmentsDentsu VenturesE12 Venture Capital, Llc+20 more

Fiddler Labs, Inc.Nov 2025 · $30M

Palo Alto, US

Amit Paka(Executive Officer, Director)Krishna Gade(Executive Officer, Director)

BoardRaviraj Jain(Director)inBilal Zuberi(Director)inGeorge Mathew(Director)in

Co-investorsDallas Venture CapitalDentsu VenturesInsight PartnersLDV PartnersLightspeed Venture PartnersLux Capital+3 more

Scalefastscalefast.cominacquired by ESW

E-commerceLogistics & Supply ChainRetail TechSaaSEl Segundo, US

Nicolas Stehle(Executive Officer, Director)Olivier Schott(Director)Philippe Bouissou(Director)

BoardEric Buatois(Director)in

Co-investorsAdara VenturesBenhamou Global VenturesFrench Partners

VarmXvarmx.comin

VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings.

BiotechHealthtechMedical Devices

Pieter ReitsmaJohn Glasspool(Chief Executive Officer)

Co-investorsSound BioventuresYsios CapitalBioGeneration VenturesEICEQT Life SciencesInkef+2 more

Zelroszelros.comin𝕏

Zelros (now part of Earnix) offers an AI decisioning and orchestration system built for insurers, covering pricing, underwriting, and customer engagement across multiple lines of business.

AI & Machine LearningInsurTechSaaS

Co-investors42CAPIsaiISAI GestionBenhamou Global Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 2

IPOs and acquisitions across the tracked portfolio

MadKuduacq. by HG InsightsScalefastacq. by ESW

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does BGV invest at?
BGV invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does BGV focus on?
BGV focuses on AI & Machine Learning, Data & Infrastructure, Enterprise Software, Robotics, SaaS, Semiconductors.
Where is BGV located?
BGV is headquartered in Silicon Valley, US.

Media · Podcasts & interviews

featuring the team

Interview with BlockStars: Yashwanth Hemaraj, BGV General Partner

Benhamou Global Ventures · Yashwanth Hemaraj

VC Strategy, with Yashwanth Hemaraj Partner at BGV | Episode #4

The Blueprint Podcast · Yashwanth Hemaraj

Keynote - Eric Benhamou (Founder, BGV) | Arka Spring Showcase '21

Arka Venture Labs · Eric Benhamou

They are Innovation - Eric BENHAMOU - Founder & Managing Director BGV | Videos & Películas en Vimeo

BLUMORPHO · Eric Benhamou · vimeo.com

IFG Network Testimonial- Anik Bose BGV - Benhamou Global Ventures on Vimeo

marcus evans summit marketing · Anik Bose · vimeo.com

IFG Network Testimonial: Anik Bose, BGV - Benhamou Global Ventures | Videos & Movies on Vimeo

IFG Network · Anik Bose · vimeo.com

Images

BGV photo

Similar investors

Featured in lists